Beacon Clinical Research is a multi-specialty clinical research facility specializing in Phase I-IV clinical trials. In 2000, Beacon Clinical Research was established to offer patients the opportunity to enroll in clinical pharmaceutical trials. Participants are significant in contributing to the development of new innovative medications. Study participation potentially benefits the individual patient and contributes to the advancement of health care in our society.

Throughout the past ten years Beacon Clinical Research has conducted clinical trials for pharmaceutical companies such as Abbott, Amgen, GSK, Merck, Pfizer and others. Beacon aims to enroll high numbers of eligible, compliant subjects, while generating and maintaining high quality source documentation and entered into EDC within 24- 48 hours. Beacon Clinical maintains continual diligence and compliance of GCP Guidelines, an important factor in both patient safety and industry standards. Throughout each trial, Beacon ensures it provides full execution of protocol with complete and accurate data. The site has established long-term relationships with multiple pharmaceutical companies and CROs.